Product
Conbercept
3 clinical trials
3 indications
Indication
Diabetic Macular EdemaIndication
Pars Plana VitrectomyIndication
ConberceptClinical trial
Protein by Dual Blockage of VEGF and FGF-2) in Subjects With Diabetic Macular Edema.Status: Completed, Estimated PCD: 2023-07-31
Clinical trial
The Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy: 12-month Results From a Prospective Multicenter Open Label StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular EdemaStatus: Recruiting, Estimated PCD: 2025-09-05